We are pleased to inform you that the n.46 of “Quaderni della SIF”, the journal edited by the Italian Pharmacology Society, has been published and includes the article “The off-label use in paediatrics”. The authors of the article, Viviana Giannuzzi (Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus) and Kejla Musaraj (Consorzio per Valutazioni Biologiche e Farmacologiche) have highlighted the importance of this theme, underlining that in the hospital environment, approximately 13-69% of paediatric prescriptions are off-label, while for not hospitalized patients the off-label use reaches at 100%, as indicated in the Report of the European Commission of 2017. Nevertheless, paediatric drugs need studies that confirm effectiveness, safety and quality on children specifically, as reported in the European Pediatric Regulation and it is necessary a wide discussion to overcome the difficulties in terms of methods, ethical and economic matters.

The full article is available at this link.

About the Author: maria


By Published On: September 16th, 2019Categories: News0 Comments